Eylea 8 mg is the first and only anti-vascular endothelial growth factor (VEGF) treatment in the EU with treatment intervals of up to 6 months for both patients with nAMD and DME.

Only 12% of the expected 733 cardiovascular deaths had occurred over 5 years in 22,071 physicians who were assigned to placebo or 325 mg aspirin on alternate days.

Learn about common-over-the-counter (OTC) treatments for migraine attacks, including acetaminophen and NSAIDs such as aspirin ...

Press Releases Aspire Biopharma Holdings, Inc., Announces Last Patient Dosed in Phase 1 Clinical Trial of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation ...

Press Releases Aspire Biopharma Holdings, Inc., Announces Last Patient Dosed in Phase 1 Clinical Trial of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation ...

Expert Rev Clin Pharmacol. 2013;6(3):271-288. 1.1 MO Recurrent headache disorder manifesting in attacks lasting 4–72 h. Typical characteristics of the headache are unilateral location, pulsating ...

Object Details maker Sterling Drug Inc. Location Currently not on view Credit Line The Fournet Drugstore Collection ID Number 1985.0475.102 accession number 1985.0475 catalog number 1985.0475.102 ...

Object Details maker Sterling Drug Inc. Location Currently not on view Credit Line The Fournet Drugstore Collection ID Number 1985.0475.101 accession number 1985.0475 catalog number 1985.0475.101 ...